Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06617923
Title	Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
Recruitment	Recruiting
Gender	female
Phase	Phase II
Variant Requirements	Yes
Sponsors	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications	endometrioid ovary carcinoma peritoneal carcinoma fallopian tube cancer fallopian tube carcinoma ovarian clear cell carcinoma
Therapies	Senaparib + Temozolomide
Age Groups:	adult \| senior
Covered Countries	USA